spacer
spacer
Go to PDB code: 
protein ligands Protein-protein interface(s) links
Transferase PDB id
2pez
Jmol
Contents
Protein chains
176 a.a. *
159 a.a. *
Ligands
GGZ
DAT ×2
Waters ×331
* Residue conservation analysis
PDB id:
2pez
Name: Transferase
Title: Crystal structrue of deletion mutant of aps-kinase domain of human paps-synthetase 1 in complex with cyclic paps and dadp
Structure: Bifunctional 3'-phosphoadenosine 5'- phosphosulfate synthetase 1 (paps synthetase 1) (papss 1) (sulfurylase kinase 1) (sk1) (sk 1). Chain: a, b. Fragment: aps-kinase domain (residues 51-226). Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: papss1, atpsk1, papss. Expressed in: escherichia coli. Expression_system_taxid: 562. Clevage site was replaced by tev site
Resolution:
1.40Å     R-factor:   0.197     R-free:   0.220
Authors: N.Sekulic,A.Lavie
Key ref:
N.Sekulic et al. (2007). Structural mechanism for substrate inhibition of the adenosine 5'-phosphosulfate kinase domain of human 3'-phosphoadenosine 5'-phosphosulfate synthetase 1 and its ramifications for enzyme regulation. J Biol Chem, 282, 22112-22121. PubMed id: 17540769 DOI: 10.1074/jbc.M701713200
Date:
03-Apr-07     Release date:   29-May-07    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
O43252  (PAPS1_HUMAN) -  Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1
Seq:
Struc:
 
Seq:
Struc:
624 a.a.
176 a.a.
Protein chain
Pfam   ArchSchema ?
O43252  (PAPS1_HUMAN) -  Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1
Seq:
Struc:
 
Seq:
Struc:
624 a.a.
159 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class 2: Chains A, B: E.C.2.7.1.25  - Adenylyl-sulfate kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: ATP + adenylyl sulfate = ADP + 3'-phosphoadenylyl sulfate
ATP
+
adenylyl sulfate
Bound ligand (Het Group name = GGZ)
matches with 90.00% similarity
=
ADP
Bound ligand (Het Group name = DAT)
matches with 96.00% similarity
+ 3'-phosphoadenylyl sulfate
   Enzyme class 3: Chains A, B: E.C.2.7.7.4  - Sulfate adenylyltransferase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: ATP + sulfate = diphosphate + adenylyl sulfate
ATP
Bound ligand (Het Group name = DAT)
matches with 83.00% similarity
+ sulfate
= diphosphate
+
adenylyl sulfate
Bound ligand (Het Group name = GGZ)
matches with 90.00% similarity
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site
 Gene Ontology (GO) functional annotation 
  GO annot!
  Biological process     sulfate assimilation   1 term 
  Biochemical function     transferase activity, transferring phosphorus-containing groups     3 terms  

 

 
    reference    
 
 
DOI no: 10.1074/jbc.M701713200 J Biol Chem 282:22112-22121 (2007)
PubMed id: 17540769  
 
 
Structural mechanism for substrate inhibition of the adenosine 5'-phosphosulfate kinase domain of human 3'-phosphoadenosine 5'-phosphosulfate synthetase 1 and its ramifications for enzyme regulation.
N.Sekulic, M.Konrad, A.Lavie.
 
  ABSTRACT  
 
In mammals, the universal sulfuryl group donor molecule 3'-phosphoadenosine 5'-phosphosulfate (PAPS) is synthesized in two steps by a bifunctional enzyme called PAPS synthetase. The APS kinase domain of PAPS synthetase catalyzes the second step in which APS, the product of the ATP-sulfurylase domain, is phosphorylated on its 3'-hydroxyl group to yield PAPS. The substrate APS acts as a strong uncompetitive inhibitor of the APS kinase reaction. We generated truncated and point mutants of the APS kinase domain that are active but devoid of substrate inhibition. Structural analysis of these mutant enzymes reveals the intrasubunit rearrangements that occur upon substrate binding. We also observe intersubunit rearrangements in this dimeric enzyme that result in asymmetry between the two monomers. Our work elucidates the structural elements required for the ability of the substrate APS to inhibit the reaction at micromolar concentrations. Because the ATP-sulfurylase domain of PAPS synthetase influences these elements in the APS kinase domain, we propose that this could be a communication mechanism between the two domains of the bifunctional enzyme.
 
  Selected figure(s)  
 
Figure 2.
FIGURE 2. The APS kinase domain consists of three rigid body parts. A, a ribbon diagram of the dimeric 50N variant of the APS kinase domain from human PAPSS1 with dADP (purple) and APS (green) in the active site. Note that both nucleotides are present only in molecule A, whereas the active site of the molecule B contains only dADP. The empty phosphoryl acceptor binding site coincides with the disordered loop between helix 6 and strand 5in molecule B. The Rigid Body 1 (RB1) region is shown in light blue in molecule A and dark blue in molecule B; Rigid Body 2 (RB2) is yellow in molecule A and orange in molecule B; the APS-cap regions are pink and red in molecules A and B, respectively. B, schematic of the 50N APS kinase dimer presented in the same color scheme as the ribbon diagram in A. Inset, schematic of an NMP kinase monomer demonstrates its similarity and difference to that of APS kinase. The three rigid bodies in NMP kinases are: lid (blue), core (yellow), and NMP binding region (pink). C, overlay of molecule A and molecule B of the 50N APS kinase variant based on C atoms belonging to residues that define RB1. Note the excellent overlay of RB1, and the different conformation of RB2 and APS-cap. D, analogous overlay as in C where C atoms from residues belonging to RB2 were used for calculating the superposition matrix. However, the APS-caps do not overlay well. Superposition of only APS-cap residues demonstrates that the APS-cap also behaves as a rigid body (inset). Together, C and D demonstrate the validity of dissecting APS kinase into three rigid bodies. Colors in C and D correspond to those in A.
Figure 7.
FIGURE 7. Schematic model for the role of helix 1 in substrate inhibition. A, in the presence of helix 1 the APS kinase can adopt a symmetric dimer. In such a state, both active sites can simultaneously bind APS and ADP, thereby forming an inhibitory complex. B, enzyme lacking helix 1 adopts an asymmetrical dimer in which one subunit has a non-functional APS-binding site. From this state (i), ADP can leave (ii), and ATP can bind (iii). To the E·ATP complex, the second substrate APS can bind resulting in a closed conformation for that monomer (iv). Concomitantly, the APS binding site of the neighboring molecule becomes non-functional, thereby eliciting APS release. See text for details.
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (2007, 282, 22112-22121) copyright 2007.  
  Figures were selected by the author.